Multifunctional nanocarriers.
By Vladimir Torchilin. Advanced Drug Delivery Reviews, 2006
852 citations recorded by the source corpus.
Subfields: Biomaterials, Biomedical Engineering, Molecular Biology
View Paper: https://www.semanticscholar.org/paper/d36e5db9288441775240fdbbdf02f1d3766a3877
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Biomaterials
In Biomedical Engineering
- S. Biswas
- Pranali P. Deshpande
- Kruti S. Soni
- T. Bronich
- S. Desale
- S. Ganta
- H. Devalapally
- Aliasgar F. Shahiwala
In Molecular Biology
- S. Biswas
- Pranali P. Deshpande
- Miqin Zhang
- M. Amiji
- S. Ganta
- H. Devalapally
- Aliasgar F. Shahiwala
- Kruti S. Soni
Citations in the corpus
- Nanogels: an overview of properties, biomedical applications and obstacles to clinical translation (2015, background): “These loading capacities are unusually high and exceed those of liposomes and polymeric micelles [3,82].”
- Current Trends and Challenges in the Clinical Translation of Nanoparticulate Nanomedicines: Pathways for Translational Development and Commercialization (2018, background): “ThermoDox R© was shown to be superior to its counterpart Doxil R© in an in vivo model of non-resectable hepatocellular carcinoma (Torchilin, 2006; Sawant and Torchilin, 2012; Oude Blenke et al., 2013; Bertrand et al., 2014; Min et al., 2015; Jang et al., 2016; Shi et al., 2017).”
- Local drug delivery strategies for cancer treatment: gels, nanoparticles, polymeric films, rods, and wafers. (2012, background): “Polymer-based drug delivery systems have been investigated over the last few decades as a means of achieving high therapeutic concentrations of chemotherapy to the site of malignant disease in cancer patients[1-10].”
- Nano based drug delivery systems: recent developments and future prospects (2018, background): “Although there are several nanocarriers with different drug release profiles, strategies are currently being formulated to improve the specificity of the nanostructures to target regions of the organism [80], and to reduce the immunogenicity through their coating or chemical functionalization with s”
- A review of stimuli-responsive nanocarriers for drug and gene delivery. (2008, background): “Preponderance of literature on nanocarrier systems is based on the use of polymeric, lipid, self-assembling, and a variety of inorganic nanoparticulate carriers [1,3,4].”
- Design and fabrication of magnetic nanoparticles for targeted drug delivery and imaging (2009, background): “Significantly, these imaging and delivery facilities have been combined into unique NP formulations through clever combinations of nanoscaled materials, enabling simultaneous in vivo diagnostic imaging and drug delivery for real-time treatment tracking [7,8].”
- Current trends in the use of liposomes for tumor targeting (2013, methodology): “Other CPPs that have been used for the modification of liposomes include the following: the minimal protein transduction domain of Antennapedia, a Drosophilia homeoprotein, called penetratin, which is a 16-mer peptide (residues 43–58) present in the third helix of the homeodomain; a 27-amino acid-lo”